p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study
Publication
, Conference
D'Amico, AV; Halabi, S; Vollmer, R; Loffredo, M; McMahon, E; Sanford, B; Archer, L; Vogelzang, NJ; Small, E; Kantoff, P
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2007
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2007
Volume
69
Issue
3
Start / End Page
S333 / S333
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
D’Amico, A. V., Halabi, S., Vollmer, R., Loffredo, M., McMahon, E., Sanford, B., … Kantoff, P. (2007). p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study. In International Journal of Radiation Oncology*Biology*Physics (Vol. 69, pp. S333–S333). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2007.07.1406
D’Amico, A. V., S. Halabi, R. Vollmer, M. Loffredo, E. McMahon, B. Sanford, L. Archer, N. J. Vogelzang, E. Small, and P. Kantoff. “p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study.” In International Journal of Radiation Oncology*Biology*Physics, 69:S333–S333. Elsevier BV, 2007. https://doi.org/10.1016/j.ijrobp.2007.07.1406.
D’Amico AV, Halabi S, Vollmer R, Loffredo M, McMahon E, Sanford B, et al. p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2007. p. S333–S333.
D’Amico, A. V., et al. “p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study.” International Journal of Radiation Oncology*Biology*Physics, vol. 69, no. 3, Elsevier BV, 2007, pp. S333–S333. Crossref, doi:10.1016/j.ijrobp.2007.07.1406.
D’Amico AV, Halabi S, Vollmer R, Loffredo M, McMahon E, Sanford B, Archer L, Vogelzang NJ, Small E, Kantoff P. p53 Protein Expression Status and Recurrence in Men Treated With Radiation Therapy and Androgen Suppression Therapy for Higher Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2007. p. S333–S333.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2007
Volume
69
Issue
3
Start / End Page
S333 / S333
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences